Evidence map›Paper›PMID 39030205›Full record

ArticleScientific reports2024

Author Correction: Comparison of CTX-M encoding plasmids present during the early phase of the ESBL pandemic in western Sweden.

Moa S Wranne, Nahid Karami, Sriram Kk, Daniel Jaén-Luchoro, Shora Yazdanshenas, Yii-Lih Lin, Arpitha Kabbinale, Carl-Fredrik Flach, Fredrik Westerlund, Christina Åhrén

Abstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Moa S WranneDepartment of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Nahid KaramiDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Guldhedsgatan 10A, 413 46, Gothenburg, Sweden. nahid.karami@microbio.gu.se.
Sriram KkDepartment of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Daniel Jaén-LuchoroDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Guldhedsgatan 10A, 413 46, Gothenburg, Sweden.
Shora YazdanshenasDepartment of Clinical Microbiology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Yii-Lih LinDepartment of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Arpitha KabbinaleDepartment of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Carl-Fredrik FlachDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Guldhedsgatan 10A, 413 46, Gothenburg, Sweden.
Fredrik WesterlundDepartment of Life Sciences, Chalmers University of Technology, Gothenburg, Sweden.
Christina ÅhrénDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Guldhedsgatan 10A, 413 46, Gothenburg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39030205
PMCPMC11259563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.